FDA Comments on Its Role in Rare Diseases & Orphan Drugs
In an effort to be more visible to the public, the FDA now publishes its own 'transparency blog". This post deals with their role in regulating orphan drugs in service of the 7000+ rare diseases.
Posted by Bruce Lehr June 22nd 2010.
via thebigredbiotechblog.typepad.com
Saw this on Bruce Lehr's Big Red Biotech blog, which I'm a fan of.
Interesting video on the FDA blog via the link his post too.
One Response to “FDA Comments on Its Role in Rare Diseases & Orphan Drugs”
Direct link to the YouTube video is here:
http://www.youtube.com/watch?v=-sKFl5lAmJE&feature=player_embedded
Of course, if the FDA can lead from the front, will we see more Pharma companies blogging too?
Perhaps not.
Comments are closed.